Bona fide gift to Reed Tuckson of 43785 shares of CTi Biopharma subject to Section 16
| CTICDelisted Stock | USD 9.09 0.00 0.00% |
About 56% of CTi Biopharma's investor base is looking to short. The analysis of current outlook of investing in CTi Biopharma Corp suggests that many traders are alarmed regarding CTi Biopharma's prospects. The current market sentiment, together with CTi Biopharma's historical and current headlines, can help investors time the market. In addition, many technical investors use CTi Biopharma Corp stock news signals to limit their universe of possible portfolio assets.
CTi |
Filed transaction by Cti Biopharma Corp director. Exempt bona fide gift subject to Rule 16b-3
Read at macroaxis.com
CTi Biopharma Fundamental Analysis
We analyze CTi Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CTi Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CTi Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
CTi Biopharma is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
CTi Biopharma Corp Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CTi Biopharma stock to make a market-neutral strategy. Peer analysis of CTi Biopharma could also be used in its relative valuation, which is a method of valuing CTi Biopharma by comparing valuation metrics with similar companies.
Peers
CTi Biopharma Related Equities
| CDTX | Cidara Therapeutics | 16.91 | ||||
| MDGL | Madrigal Pharmaceuticals | 5.53 | ||||
| MCRB | Seres Therapeutics | 5.48 | ||||
| IMMP | Immutep | 4.89 | ||||
| RIGL | Rigel Pharmaceuticals | 3.99 | ||||
| FBIO | Fortress Biotech | 2.55 | ||||
| PLX | Protalix Biotherapeutics | 1.81 | ||||
| VSTM | Verastem | 1.78 | ||||
| TGTX | TG Therapeutics | 1.51 | ||||
| IBRX | Immunitybio | 1.19 | ||||
| CRVS | Corvus Pharmaceuticals | 0.11 | ||||
| ELEV | Elevation Oncology | 1.64 | ||||
| VKTX | Viking Therapeutics | 1.83 | ||||
| PDSB | PDS Biotechnology | 5.00 | ||||
| RVPH | Reviva Pharmaceuticals | 8.06 | ||||
| XFOR | X4 Pharmaceuticals | 8.11 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in CTi Stock
If you are still planning to invest in CTi Biopharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CTi Biopharma's history and understand the potential risks before investing.
| CEOs Directory Screen CEOs from public companies around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |